Cardiff Lexington Corp (CDIX) stock
CDIXOTCServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
$0.04−0.01 (-25.53%)
Close on Oct 19, 2026Market cap $550.31KP/E –Yield –
Cardiff Lexington operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Cardiff Lexington's operating income for the twelve months ending Sep 30, 2026 was -$2.29M, down 207.5% year over year. For fiscal 2025 it was $1.10M. The highest annual figure on record is $5.20M in fiscal 2023.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.10M | – |
| FY2024 | Dec 31, 2024 | -$193.50K | -103.7% |
| FY2023 | Dec 31, 2023 | $5.20M | +33.0% |
| FY2022 | Dec 31, 2022 | $3.91M | +135.1% |
| FY2021 | Dec 31, 2021 | $1.66M | – |
| FY2020 | Dec 31, 2020 | -$1.80M | – |
| FY2019 | Dec 31, 2019 | -$1.27M | – |
| FY2018 | Dec 31, 2018 | -$2.02M | – |
| FY2017 | Dec 31, 2017 | -$2.99M | – |
| FY2016 | Dec 31, 2016 | -$2.16M | – |
| FY2015 | Dec 31, 2015 | -$3.91M | – |
| FY2014 | Dec 31, 2014 | -$12.45M | – |
| FY2013 | Dec 31, 2013 | -$11.04M | – |
| FY2012 | Dec 31, 2012 | -$819.23K | – |
| FY2011 | Dec 31, 2011 | -$1.09M | – |
| FY2010 | Dec 31, 2010 | -$1.42M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$536.67K | -183.4% |
| Q2 FY2026 | Jun 30, 2026 | -$544.64K | -189.3% |
| Q1 FY2026 | Mar 31, 2026 | -$511.16K | -194.0% |
| Q4 FY2025 | Dec 31, 2025 | -$696.30K | -309.6% |
| Q3 FY2025 | Sep 30, 2025 | $643.28K | – |
| Q2 FY2025 | Jun 30, 2025 | $609.68K | – |
| Q1 FY2025 | Mar 31, 2025 | $543.93K | +148.4% |
| Q4 FY2024 | Dec 31, 2024 | $332.15K | -19.9% |
| Q3 FY2024 | Sep 30, 2024 | -$585.16K | -125.7% |
| Q2 FY2024 | Jun 30, 2024 | -$159.48K | -109.1% |
| Q1 FY2024 | Mar 31, 2024 | $218.99K | -71.1% |
| Q4 FY2023 | Dec 31, 2023 | $414.66K | -29.2% |
| Q3 FY2023 | Sep 30, 2023 | $2.27M | +51.8% |
| Q2 FY2023 | Jun 30, 2023 | $1.75M | +55.8% |
| Q1 FY2023 | Mar 31, 2023 | $757.55K | +5.0% |
| Q4 FY2022 | Dec 31, 2022 | $585.68K | -82.4% |
| Q3 FY2022 | Sep 30, 2022 | $1.50M | +40.4% |
| Q2 FY2022 | Jun 30, 2022 | $1.12M | – |
| Q1 FY2022 | Mar 31, 2022 | $721.48K | – |
| Q4 FY2021 | Dec 31, 2021 | $3.33M | – |
| Q3 FY2021 | Sep 30, 2021 | $1.07M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.36M | – |
| Q1 FY2021 | Mar 31, 2021 | -$375.85K | – |
| Q4 FY2020 | Dec 31, 2020 | -$912.52K | – |
| Q3 FY2020 | Sep 30, 2020 | -$530.57K | -439.4% |
| Q2 FY2020 | Jun 30, 2020 | -$126.83K | – |
| Q1 FY2020 | Mar 31, 2020 | -$233.95K | – |
| Q4 FY2019 | Dec 31, 2019 | -$818.88K | – |
| Q3 FY2019 | Sep 30, 2019 | $156.34K | – |
| Q2 FY2019 | Jun 30, 2019 | -$400.14K | – |
| Q1 FY2019 | Mar 31, 2019 | -$207.94K | – |
| Q4 FY2018 | Dec 31, 2018 | -$336.96K | – |
| Q3 FY2018 | Sep 30, 2018 | -$916.02K | – |
| Q2 FY2018 | Jun 30, 2018 | -$395.84K | – |
| Q1 FY2018 | Mar 31, 2018 | -$372.20K | – |
| Q4 FY2017 | Dec 31, 2017 | -$595.59K | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.32M | – |
| Q2 FY2017 | Jun 30, 2017 | -$633.60K | – |
| Q1 FY2017 | Mar 31, 2017 | -$445.33K | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.18M | – |
See a number that looks wrong?